Given investment horizon of 30 days, Generex Biotechnology Corporation is expected to under-perform the Elan. In addition to that, Generex is 1.49 times more volatile than Elan Corporation plc. It trades about -0.07 of its total potential returns per unit of risk. Elan Corporation plc is currently generating about 0.06 per unit of volatility. If you would invest 1,390 in Elan Corporation plc on April 26, 2012 and sell it today you would earn a total of 40.00 from holding Elan Corporation plc or generate 2.88% return on investment over 30 days.
Diversification
Very good diversification
Overlapping area represents amount of risk that can be diversified away by holding Generex Biotechnology Corp. and Elan Corp. plc in the same portfolio (assuming nothing else is changed)
98% of all equities and portfolios perform better than Elan Corporation plc. Compared with the overall equity markets, risk-adjusted returns on investments in Elan Corporation plc are ranked lower than 2 (%) of all global equities and portfolios over the last 30 days.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
